Effects of angiotensin-receptor neprilysin inhibitor on exercise capacity, quality of life, and cardiac function in heart failure with preserved ejection fraction: a protocol for meta-analysis

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽

Effects of angiotensin-receptor neprilysin inhibitor on exercise capacity, quality of life, and cardiac function in heart failure with preserved ejection fraction

Medicine: Case Reports and Study Protocols ◽

10.1097/md9.0000000000000160 ◽

2021 ◽

Vol 2 (10) ◽

pp. e0160

Author(s):

Hidekatsu Fukuta ◽

Hiromi Hagiwara ◽

Takeshi Kamiya

Keyword(s):

Quality Of Life ◽

Heart Failure ◽

Ejection Fraction ◽

Cardiac Function ◽

Exercise Capacity ◽

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽

Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

Heart Failure Reviews ◽

10.1007/s10741-019-09774-5 ◽

2019 ◽

Vol 24 (4) ◽

pp. 535-547 ◽

Cited By ~ 14

Author(s):

Hidekatsu Fukuta ◽

Toshihiko Goto ◽

Kazuaki Wakami ◽

Takeshi Kamiya ◽

Nobuyuki Ohte

Keyword(s):

Quality Of Life ◽

Heart Failure ◽

Exercise Training ◽

Ejection Fraction ◽

Cardiac Function ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled

GW29-e0618 A Meta-analysis of the effect of exercise training on exercise capacity and quality of life in patients with heart failure with preserved ejection fraction.

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2018.08.1021 ◽

2018 ◽

Vol 72 (16) ◽

pp. C239

Author(s):

Lingling Wu ◽

Yingying Zheng ◽

PengYang Li ◽

Jiangui He

Keyword(s):

Quality Of Life ◽

Heart Failure ◽

Exercise Training ◽

Ejection Fraction ◽

Exercise Capacity ◽

Meta Analysis ◽

Patients With Heart Failure

Angiotensin Receptor-Neprilysin Inhibitor Therapy for Heart Failure With Preserved Ejection Fraction Improves Renal Outcomes

Circulation ◽

10.1161/circulationaha.120.050398 ◽

2020 ◽

Vol 142 (13) ◽

pp. 1246-1248

Author(s):

Sheldon W. Tobe ◽

Stephanie Poon

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Inhibitor Therapy ◽

Angiotensin Receptor ◽

Renal Outcomes ◽

Neprilysin Inhibitor ◽

Elevation in High-Sensitivity Troponin T in Heart Failure and Preserved Ejection Fraction and Influence of Treatment With the Angiotensin Receptor Neprilysin Inhibitor LCZ696

Circulation Heart Failure ◽

10.1161/circheartfailure.114.001427 ◽

2014 ◽

Vol 7 (6) ◽

pp. 953-959 ◽

Cited By ~ 56

Author(s):

Pardeep S. Jhund ◽

Brian L. Claggett ◽

Adriaan A. Voors ◽

Michael R. Zile ◽

Milton Packer ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Troponin T ◽

High Sensitivity ◽

Angiotensin Receptor ◽

High Sensitivity Troponin ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

High Sensitivity Troponin T

The effect of exercise training and physiotherapy on diastolic function, exercise capacity and quality of life in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis

Kardiologia Polska ◽

10.33963/kp.a2021.0101 ◽

2021 ◽

Vol 79 (10) ◽

pp. 1107-1115

Author(s):

Chenchen Zhuang ◽

Xufei Luo ◽

Qiongying Wang ◽

Wenjuan Wang ◽

Runmin Sun ◽

...

Keyword(s):

Quality Of Life ◽

Heart Failure ◽

Systematic Review ◽

Exercise Training ◽

Ejection Fraction ◽

Diastolic Function ◽

Meta Analysis ◽

Patients With Heart Failure

Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials

European Journal of Preventive Cardiology ◽

10.1177/2047487314564729 ◽

2014 ◽

Vol 23 (1) ◽

pp. 78-85 ◽

Cited By ~ 47

Author(s):

Hidekatsu Fukuta ◽

Toshihiko Goto ◽

Kazuaki Wakami ◽

Nobuyuki Ohte

Keyword(s):

Quality Of Life ◽

Heart Failure ◽

Ejection Fraction ◽

Functional Capacity ◽

Exercise Intervention ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled

THE ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI), SACUBITRIL/VALSARTAN, IMPROVES LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (PARAMOUNT TRIAL)

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(18)33206-6 ◽

2018 ◽

Vol 71 (11) ◽

pp. A2665 ◽

Cited By ~ 4

Author(s):

Tor Biering-Sorensen ◽

Amil Shah ◽

Brian Claggett ◽

Michael Zile ◽

Burkert Pieske ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Left Ventricular ◽

Myocardial Deformation ◽

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽

LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice

European Journal of Heart Failure ◽

10.1002/ejhf.474 ◽

2016 ◽

Vol 18 (4) ◽

pp. 386-393 ◽

Cited By ~ 68

Author(s):

Yasunori Suematsu ◽

Shin-ichiro Miura ◽

Masaki Goto ◽

Yoshino Matsuo ◽

Tadaaki Arimura ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Cardiac Function ◽

Diabetic Mice ◽

Angiotensin Receptor ◽

Reduced Ejection Fraction ◽

Neprilysin Inhibitor ◽

THE EFFICACY OF THE ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR, LCZ696, IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION IS INDEPENDENT OF BLOOD PRESSURE LOWERING

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(14)60812-3 ◽

2014 ◽

Vol 63 (12) ◽

pp. A812

Author(s):

Pardeep Jhund ◽

Brian Claggett ◽

Milton Packer ◽

Michael Zile ◽

Adriaan Voors ◽

...

Keyword(s):

Heart Failure ◽

Blood Pressure ◽

Ejection Fraction ◽

Angiotensin Receptor ◽

Blood Pressure Lowering ◽

Neprilysin Inhibitor ◽

Patients With Heart Failure ◽

Pressure Lowering ◽